Main Features of Impaired Fibronolytic and Protolytic Activity of Blood Plasma in Patients with Osteoarthritis Depending on Comorbidity

The objective of the research was to study the features of impaired fibrinolytic and proteolytic activity of blood plasma in patients with osteoarthritis (OA), depending on the age levels of comorbidity. Material and methods. The age features of comorbid processes prevalence in 120 patients with OA...

Full description

Bibliographic Details
Main Author: Larysa Voloshyna
Format: Article
Language:English
Published: Ivano-Frankivsk National Medical University 2016-12-01
Series:Galician Medical Journal
Subjects:
Online Access:https://ifnmujournal.com/gmj/article/view/692
_version_ 1831537956414816256
author Larysa Voloshyna
author_facet Larysa Voloshyna
author_sort Larysa Voloshyna
collection DOAJ
description The objective of the research was to study the features of impaired fibrinolytic and proteolytic activity of blood plasma in patients with osteoarthritis (OA), depending on the age levels of comorbidity. Material and methods. The age features of comorbid processes prevalence in 120 patients with OA were clinically studied, fibrinolytic and proteolytic activity of blood, levels of fibrinogen and C-reactive protein were also studied using biochemical methods. Results. Comorbidity in patients with OA at the age under 50 was established low. The level of comorbidity increases to at the age of 51-60, after 60 years the phenomenon of comorbidity is more significant by frequency and severity. The diseases of the cardiovascular system dominated, including metabolic syndrome, diseases of the digestive tract and kidneys were less frequent. Cardiovascular risk (CVR) levels were high after the age of 50, gastrointestinal risk was less frequent. Fibrinolysis minor disorders were observed in patients with low comorbidity, namely fibrinolytic and proteolytic activity of blood as a part of high CVR progressively deteriorated and the level of fibrinogen and C-reactive protein increased in the patients at the age after 50 (especially 60) on the background of high comorbidity levels.  Conclusions. The level of comorbidity and CVR increased in patients with OA with age, increase in disease severity and duration. These phenomena were accompanied by progressive disorders in fibrinolytic and proteolytic activity of the blood, increased levels of fibrinogen and C-reactive protein as one of the components of CVR.
first_indexed 2024-12-16T23:15:40Z
format Article
id doaj.art-5d3e89d7552843e3a257edbfced78238
institution Directory Open Access Journal
issn 2414-1518
language English
last_indexed 2024-12-16T23:15:40Z
publishDate 2016-12-01
publisher Ivano-Frankivsk National Medical University
record_format Article
series Galician Medical Journal
spelling doaj.art-5d3e89d7552843e3a257edbfced782382022-12-21T22:12:18ZengIvano-Frankivsk National Medical UniversityGalician Medical Journal2414-15182016-12-01234E2016417E201641710.21802/gmj.2016.4.17692Main Features of Impaired Fibronolytic and Protolytic Activity of Blood Plasma in Patients with Osteoarthritis Depending on ComorbidityLarysa Voloshyna0Bukovinian State Medical UniversityThe objective of the research was to study the features of impaired fibrinolytic and proteolytic activity of blood plasma in patients with osteoarthritis (OA), depending on the age levels of comorbidity. Material and methods. The age features of comorbid processes prevalence in 120 patients with OA were clinically studied, fibrinolytic and proteolytic activity of blood, levels of fibrinogen and C-reactive protein were also studied using biochemical methods. Results. Comorbidity in patients with OA at the age under 50 was established low. The level of comorbidity increases to at the age of 51-60, after 60 years the phenomenon of comorbidity is more significant by frequency and severity. The diseases of the cardiovascular system dominated, including metabolic syndrome, diseases of the digestive tract and kidneys were less frequent. Cardiovascular risk (CVR) levels were high after the age of 50, gastrointestinal risk was less frequent. Fibrinolysis minor disorders were observed in patients with low comorbidity, namely fibrinolytic and proteolytic activity of blood as a part of high CVR progressively deteriorated and the level of fibrinogen and C-reactive protein increased in the patients at the age after 50 (especially 60) on the background of high comorbidity levels.  Conclusions. The level of comorbidity and CVR increased in patients with OA with age, increase in disease severity and duration. These phenomena were accompanied by progressive disorders in fibrinolytic and proteolytic activity of the blood, increased levels of fibrinogen and C-reactive protein as one of the components of CVR.https://ifnmujournal.com/gmj/article/view/692osteoarthritiscomorbidityfibrinolyticproteolytic activity levels
spellingShingle Larysa Voloshyna
Main Features of Impaired Fibronolytic and Protolytic Activity of Blood Plasma in Patients with Osteoarthritis Depending on Comorbidity
Galician Medical Journal
osteoarthritis
comorbidity
fibrinolytic
proteolytic activity levels
title Main Features of Impaired Fibronolytic and Protolytic Activity of Blood Plasma in Patients with Osteoarthritis Depending on Comorbidity
title_full Main Features of Impaired Fibronolytic and Protolytic Activity of Blood Plasma in Patients with Osteoarthritis Depending on Comorbidity
title_fullStr Main Features of Impaired Fibronolytic and Protolytic Activity of Blood Plasma in Patients with Osteoarthritis Depending on Comorbidity
title_full_unstemmed Main Features of Impaired Fibronolytic and Protolytic Activity of Blood Plasma in Patients with Osteoarthritis Depending on Comorbidity
title_short Main Features of Impaired Fibronolytic and Protolytic Activity of Blood Plasma in Patients with Osteoarthritis Depending on Comorbidity
title_sort main features of impaired fibronolytic and protolytic activity of blood plasma in patients with osteoarthritis depending on comorbidity
topic osteoarthritis
comorbidity
fibrinolytic
proteolytic activity levels
url https://ifnmujournal.com/gmj/article/view/692
work_keys_str_mv AT larysavoloshyna mainfeaturesofimpairedfibronolyticandprotolyticactivityofbloodplasmainpatientswithosteoarthritisdependingoncomorbidity